Akiva Mintz, M.D., Ph.D., Assistant Professor Surgical Sciences-Neurosurgery

Akiva Mintz, M.D., Ph.D.

Assistant Professor, Neurosurgery
Comprehensive Cancer Center
Brain Tumor Center of Excellence
Center for Biomolecular Imaging
Radiology
Cancer Biology

Clinical Specialties

Noninvasive Imaging, Nuclear Medicine Oncologic Imaging, PET/CT, Molecular Imaging

Contact Information

Academic: 336-716-4857 | Department: 336-716-4081

Email: amintz@wakehealth.edu

Education & Training

B.A., CUNY Brooklyn College , 1997
M.D., Penn State University College of Medicine , 2004
Ph.D., Penn State University College of Medicine , 2002
Internship, Medicine, Lehigh Valley Hosp Ctr, 2005
Residency, Nuclear Medicine, Hosp Of The Univ Penn, 2008
Fellowship, Nuclear Medicine, University of Pennsylvania, 2008

Board Certifications

American Board of Nuclear Medicine, Nuclear Medicine

Memberships

Society of Neuro-Oncology
Soc Of Nuclear Medicine
Radiological Soc of North Amer

NPI Number

1245389956

Akiva Mintz, M.D., Ph.D.

Assistant Professor, Neurosurgery Comprehensive Cancer Center
Brain Tumor Center of Excellence
Center for Biomolecular Imaging
Radiology
Cancer Biology

Research Interests

biotechnology, cancer/oncogenesis, drugs/therapeutic agents pharm

Contact Information

Academic: 336-716-4857 | Department: 336-716-4081

Email: amintz@wakehealth.edu

Recent Publications

Birbrair A, Zhang T, Wang ZM, Messi ML, Enikolopov GN, Mintz A, Delbono O. Skeletal muscle neural progenitor cells exhibit properties of NG2-glia. Exp Cell Res. 2013;319(1):45-63.

Birbrair A, Zhang T, Wang Z-M, Messi ML, Enikolopov GN, Mintz A, Delbono O. Skeletal muscle pericyte subtypes differ in their differentiation potential. Stem Cell Res. 2013;10(1):67-84.

Kota G, Gupta P, Mintz A. PET/CT illustration of metastatic breast cancer to the left mandibular foramen. Clin Nucl Med. 2013;38(5):385-386.

Deford-Watts LM, Mintz A, Kridel SJ. The potential of 11C-acetate PET for monitoring the fatty acid synthesis pathway in tumors. Curr Pharm Biotechnol. 2013;14(3):300-312.

Gupta P, Kota G, Mintz A. Evolution of a ureteric stone from the renal pelvis to the ureter on skeletal scintigraphy with CT correlation. Clin Nucl Med. 2012;37(2):188-189.

Beauchamp A, Lively MO, Mintz A, Gibo D, Wykosky J, Debinski W. EphrinA1 is released in three forms from cancer cells by matrix metalloproteases. Mol Cell Biol. 2012;32(16):3253-3264.

Nguyen V, Conyers JM, Zhu D, Gibo DM, Hantgan RR, Larson SM, Debinski W, Mintz A. A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13R alpha2 tumor-restricted biomarker. Neuro Oncol. 2012;14(10):1239-1253.

Kota G, Gupta P, Wilson J, Lesser G, Mintz A. Metastatic intracranial hemangiopericytoma: the role of octreotide and PET imaging in diagnosis, pre-treatment and follow-up evaluation [abstract]. J Nucl Med. 2011;52(Suppl 1):abstr 1065.

Gupta P, Kota G, Alavi A, Mintz A. Unilateral diffusely increased muscle uptake of F-18 FDG in a patient with hemiparesis due to stroke. Clin Nucl Med. 2011;36(12):1140-1141.

Nguyen V, Conyers JM, Zhu D, Gibo DM, Dorsey JF, Debinski W, Mintz A. IL-13R alpha2-targeted therapy escapees: biologic and therapeutic implications. Transl Oncol. 2011;4(6):390-400.

Nguyen V, Conyers JM, Mintz A. Pretargeting the masses: a means of improving and mainstreaming targeted molecular delivery? [commentary]. Cancer Biol Ther. 2010;10(8):775-779.

Kota GK, Gupta P, Conyers JM, Mintz A. Targeting angiogenesis in an age of personalized medicine [commentary]. Cancer Biol Ther. 2010;10(9):874-877.

Hammond SN, Norden AD, Drappatz J, Phuphanich S, Reardon D, Wong ET, Plotkin SR, Lesser G, Mintz A, Raizer JJ, et al. Phase II study of monthly pasireotide LAR (Som230C) for recurrent or progressive meningioma [abstract]. Neuro Oncol. 2010;12(Suppl 4):71.

Nguyen V, Murphy LT, Beauchamp AS, Hollingsworth CK, Debinski W, Mintz A. Combinatorial targeting of EphA2 and IL-13Ralpha2 GBM-restricted biomarkers [abstract]. Neuro Oncol. 2010;12(Suppl 4):97.

Dorsey JF, Mintz A, Tian X, Dowling ML, Plastaras JP, Dicker DT, Kao GD, El-Deiry WS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. Mol Cancer Ther. 2009;8(12):3285-3295.

Nguyen V, Mintz A. New frontiers in biomarker-targeted molecular imaging [commentary]. Cancer Biol Ther. 2009;8(23):2235-2238.

Mintz A, Gibo DM, MadhanKumar AB, Cladel NM, Christensen ND, Debinski W. Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2. Cancer Biother Radiopharm. 2008;23(5):581-589.